News Focus
News Focus
icon url

MahinAgency

11/06/24 10:59 AM

#214 RE: williams45 #191

NASDAQ: CRDL is advancing CardiolRx™ for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million
icon url

MahinAgency

11/14/24 2:48 PM

#234 RE: williams45 #191

NASDAQ: $CRDL lets See Red To Green, 

H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

The company recently raised $13.5 million
Bullish
Bullish
icon url

MahinAgency

11/15/24 2:31 PM

#237 RE: williams45 #191

NASDAQ: $CRDL SHORT SQUEEZE ALERTS, STAY TUNED

Addressing urgent unmet medical needs: CardiolRx™ targets acute myocarditis, a life-threatening condition with no FDA-approved treatments
Bullish
Bullish